Robert W. Sponzo

3.3k total citations · 1 hit paper
23 papers, 2.5k citations indexed

About

Robert W. Sponzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Robert W. Sponzo has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Robert W. Sponzo's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Robert W. Sponzo is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Robert W. Sponzo collaborates with scholars based in United States and Thailand. Robert W. Sponzo's co-authors include John Horton, Martin M. Oken, Roland T. Skeel, Murray N. Silverstein, Ediz Z. Ezdinli, Charles Rosenbaum, John M. Bennett, Gerhard J. Johnson, Charles G. Moertel and Colin B. Begg and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Robert W. Sponzo

23 papers receiving 2.4k citations

Hit Papers

Prognostic effect of weight loss prior tochemotherapy in ... 1980 2026 1995 2010 1980 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. Sponzo United States 13 1.4k 700 491 411 389 23 2.5k
Charles Rosenbaum United States 10 1.4k 1.0× 743 1.1× 573 1.2× 405 1.0× 345 0.9× 13 2.3k
Charles P. Perlia United States 16 1.4k 1.0× 806 1.2× 427 0.9× 417 1.0× 368 0.9× 26 2.6k
Murray N. Silverstein United States 28 1.6k 1.1× 613 0.9× 338 0.7× 423 1.0× 559 1.4× 66 4.5k
Harold O. Douglass United States 26 1.5k 1.0× 1.5k 2.1× 1.3k 2.7× 442 1.1× 1.4k 3.5× 70 4.2k
I. Monteiro Grillo Portugal 16 1.5k 1.1× 732 1.0× 381 0.8× 338 0.8× 354 0.9× 36 2.3k
Aoife M. Ryan Ireland 31 1.9k 1.3× 998 1.4× 615 1.3× 367 0.9× 1.1k 2.9× 68 3.3k
Benjamin Tan United Kingdom 18 1.6k 1.1× 466 0.7× 307 0.6× 194 0.5× 537 1.4× 36 2.1k
Senji Okuno Japan 30 487 0.3× 304 0.4× 360 0.7× 541 1.3× 475 1.2× 100 3.3k
K.C.H. Fearon United Kingdom 15 1.1k 0.7× 443 0.6× 113 0.2× 273 0.7× 632 1.6× 28 1.8k
Tora S. Solheim Norway 23 1.4k 1.0× 585 0.8× 228 0.5× 213 0.5× 233 0.6× 66 2.0k

Countries citing papers authored by Robert W. Sponzo

Since Specialization
Citations

This map shows the geographic impact of Robert W. Sponzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Sponzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Sponzo more than expected).

Fields of papers citing papers by Robert W. Sponzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Sponzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Sponzo. The network helps show where Robert W. Sponzo may publish in the future.

Co-authorship network of co-authors of Robert W. Sponzo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Sponzo. A scholar is included among the top collaborators of Robert W. Sponzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Sponzo. Robert W. Sponzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haluska, Paul, Albert M. Bernath, Karla V. Ballman, et al.. (2014). Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).. Journal of Clinical Oncology. 32(15_suppl). 632–632. 10 indexed citations
2.
Bowen, Deborah J., Alan Kuniyuki, Ann L. Shattuck, Daniel W. Nixon, & Robert W. Sponzo. (2000). Results of a volunteer program to conduct dietary intervention research for women. Annals of Behavioral Medicine. 22(1). 94–100. 3 indexed citations
3.
Castro, Michael, et al.. (1999). Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma. Cancer. 85(5). 1055–1059. 42 indexed citations
4.
Kristal, Alan R., Ann L. Shattuck, Deborah J. Bowen, Robert W. Sponzo, & Daniel W. Nixon. (1997). Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: the American Cancer Society Breast Cancer Dietary Intervention Project.. PubMed. 6(6). 459–67. 30 indexed citations
5.
Ruckdeschel, John C., Cyrus R. Mehta, Omar M. Salazar, Richard H. Creech, & Robert W. Sponzo. (1982). Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.. PubMed. 65(11-12). 959–63. 15 indexed citations
7.
DeWys, William D., Colin B. Begg, Philip T. Lavin, et al.. (1980). Prognostic effect of weight loss prior tochemotherapy in cancer patients. The American Journal of Medicine. 69(4). 491–497. 1785 indexed citations breakdown →
8.
Sponzo, Robert W., et al.. (1979). Management of non-resectable (stage III) breast cancer. International Journal of Radiation Oncology*Biology*Physics. 5(9). 1475–1478. 15 indexed citations
9.
Lempert, Neil, Allastair M. Karmody, Thomas J. Cunningham, et al.. (1979). Vascular access for cancer chemotherapy. Cancer. 43(5). 1934–1936. 11 indexed citations
10.
Nemoto, Takuma, Dutzu Rosner, Thomas L. Dao, et al.. (1978). Combination chemotherapy for metastatic breast cancer.Comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy. Cancer. 41(6). 2073–2077. 32 indexed citations
11.
Cunningham, Thomas J., et al.. (1977). Hexamethylmelamine, vincristine, and methotrexate chemotherapy in advanced neoplasms.. PubMed. 61(5). 919–22. 7 indexed citations
12.
Cunningham, Thomas J., et al.. (1976). ADJUVANT IMMUNO‐ AND/OR CHEMOTHERAPY WITH NEURAMINIDASE‐TREATED AUTOGENOUS TUMOR VACCINE AND BACILLUS CALMETTEGUÉRIN FOR HEAD AND NECK CANCERS*. Annals of the New York Academy of Sciences. 277(1). 339–344. 12 indexed citations
13.
14.
Cunningham, Thomas J., et al.. (1976). Intracavitary bleomycin in the management of malignant effusions. Cancer. 38(5). 1903–1908. 136 indexed citations
16.
Sponzo, Robert W., James C. Arseneau, & George P. Canellos. (1974). Procarbazine Induced Oxidative Haemolysis: Relationship to in Vivo Red Cell Survival. British Journal of Haematology. 27(4). 587–595. 9 indexed citations
17.
Ba, Chabner, Robert W. Sponzo, S M Hubbard, et al.. (1974). High-dose intermittent intravenous infusion of procarbazine (NSC-77213).. PubMed. 57(3). 361–3. 7 indexed citations
18.
Matthay, Richard A., et al.. (1974). Salmonella Typhimurium Abscess Formation in a Calcified Ventricular Aneurysm. CHEST Journal. 66(4). 457–459. 10 indexed citations
19.
Horton, John, et al.. (1974). The chemotherapy of large-bowel cancer present status and future prospects. Digestive Diseases and Sciences. 19(11). 1040–1046. 7 indexed citations
20.
Arseneau, James C., Robert W. Sponzo, David L. Levin, et al.. (1972). Nonlymphomatous Malignant Tumors Complicating Hodgkin's Disease. New England Journal of Medicine. 287(22). 1119–1122. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026